Success Metrics

Clinical Success Rate
85.7%

Based on 18 completed trials

Completion Rate
86%(18/21)
Active Trials
1(4%)
Results Posted
56%(10 trials)
Terminated
3(12%)

Phase Distribution

Ph early_phase_1
1
4%
Ph phase_3
2
8%
Ph phase_4
8
31%
Ph phase_2
3
12%
Ph not_applicable
11
42%
Ph phase_1
1
4%

Phase Distribution

2

Early Stage

3

Mid Stage

10

Late Stage

Phase Distribution26 total trials
Early Phase 1First-in-human
1(3.8%)
Phase 1Safety & dosage
1(3.8%)
Phase 2Efficacy & side effects
3(11.5%)
Phase 3Large-scale testing
2(7.7%)
Phase 4Post-market surveillance
8(30.8%)
N/ANon-phased studies
11(42.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

18 of 22 finished

Non-Completion Rate

18.2%

4 ended early

Currently Active

1

trials recruiting

Total Trials

26

all time

Status Distribution
Active(1)
Completed(18)
Terminated(4)
Other(3)

Detailed Status

Completed18
Terminated3
unknown3
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.8%)
Phase 11 (3.8%)
Phase 23 (11.5%)
Phase 32 (7.7%)
Phase 48 (30.8%)
N/A11 (42.3%)

Trials by Status

recruiting14%
terminated312%
unknown312%
withdrawn14%
completed1869%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT05619289Phase 2

Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn

Completed
NCT03621553Phase 4

Vitamin D Homeostasis in Sarcoidosis

Recruiting
NCT03046927Phase 2

Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes

Completed
NCT01568255Phase 4

Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms

Completed
NCT03747523Early Phase 1

Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels

Completed
NCT00288873Phase 4

Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity

Completed
NCT00491322Not Applicable

Vitamin D Deficiency, Insulin Resistance and FGF-23

Completed
NCT00892099Not Applicable

DIVINE: Dialysis Infection and Vitamin D In New England

Completed
NCT03228862Phase 4

Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults

Unknown
NCT01173848Phase 3

Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients

Terminated
NCT00621257Not Applicable

Vitamin D Levels in Children With IBD

Terminated
NCT01426347Not Applicable

Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis

Completed
NCT01774812Phase 2

Vitamin D and Cardiac Autonomic Tone in Hemodialysis

Completed
NCT02011828Phase 1

Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol

Completed
NCT00742235Not Applicable

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

Completed
NCT01312441Phase 4

Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D

Terminated
NCT01026363Not Applicable

hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease

Withdrawn
NCT01180946Not Applicable

Vitamin D Deficiency in Adolescent Girls

Completed
NCT01570309Not Applicable

Vitamin D Repletion in Coronary Artery Disease

Completed
NCT01295879Phase 4

Vitamin D Repletion in Stone Formers With Hypercalciuria

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26